Alshaymaa Ahmed Ibrahim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alshaymaa Ahmed Ibrahim has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
- Ingy Ashmawy
Department of Clinical and Chemical Pathology, Medical Research and Clinical Studies Institute, National Research Centre, Cairo, Egypt
5 shared publications Tamer A. Abdel Hamid
Pediatric Department, Faculty of Medicine, Cairo University, Egypt
5 shared publicationsAliaa Ahmed Wahby
3 shared publications- Abeer Selim
Department of Pediatrics, Medical Research and Clinical Studies Institute, National Research Centre, Cairo, Egypt
2 shared publications - Aliaa Ahmed Wahby
Department of Clinical Pathology, Medical Research and Clinical Studies Institute, National Research Centre, Cairo, Egypt
2 shared publications - Dalia Adel Abd El-Haleem
Department of Clinical and Chemical Pathology, Medical Research Division, National Research Centre, Cairo, Egypt
2 shared publications
Latest Publications
- 1 December 2020
- Published by Elsevier in Gene Reports
- Vol. 21
Perforin A and granzyme B as non invasive markers in early acute rejection in pediatric renal transplantation
- 1 December 2020
- Published by Elsevier in Gene Reports
- Vol. 21
Perforin A and granzyme B as non invasive markers in early acute rejection in pediatric renal transplantation
- Open Access
- 25 November 2020
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 12  (4) , 401-409
Association of Exosomal miR-34a with Markers of Dyslipidemia and Endothelial Dysfunction in Children and Adolescents with T1DM
Dyslipidemia and endothelial dysfunction are common disorders and major causative factors for atherosclerosis in patients with T1DM. However, their pathophysiology in young patients with T1DM is still under evaluated. We aimed for the first time to assess the expression of exosomal miR-34a in serum of children and adolescents with T1DM and correlate this expression with markers of dyslipidemia and endothelial dysfunction. The study included 120 T1DM patients and 100 control subjects. Assessment of exosomal miR-34a was done using qRT PCR. Measurement of Lipid profile was done using automated analyzer and serum endoglin and intracellular adhesion molecule (ICAM) levels were measured using ELISA technique. Relative expression of miR-34a and serum endoglin and ICAM levels were higher in patients than controls and in in patients with dyslipidemia (42 patients) compared to patients without dyslipidemia (78 patients) (p=0.001, 0.01 respectively). Linear regression analysis revealed strong an independent association between exosomal miR-34a expression with those of total cholesterol, LDL, serum endoglin and serum ICAM after adjustment of other cofactors. The utility of miR-34a as indicator for associated dyslipidemia was tested using ROC curve which revealed AUC: 0.73 with CI:0.63-0.83 and p=0.001. This is the first study that reported the altered expression of exosomal miR-34a among children and adolescents with T1DM. Moreover, association of miR-34a with markers of dyslipidemia and endothelial dysfunction was identified, suggesting that it could play a role in regulation of lipid metabolism and endothelial function in T1DM.
- 25 November 2020
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 12  (4) , 401-409
Open AccessAssociation of Exosomal miR-34a with Markers of Dyslipidemia and Endothelial Dysfunction in Children and Adolescents with T1DM
Dyslipidemia and endothelial dysfunction are common disorders and major causative factors for atherosclerosis in patients with T1DM. However, their pathophysiology in young patients with T1DM is still under evaluated. We aimed for the first time to assess the expression of exosomal miR-34a in serum of children and adolescents with T1DM and correlate this expression with markers of dyslipidemia and endothelial dysfunction. The study included 120 T1DM patients and 100 control subjects. Assessment of exosomal miR-34a was done using qRT PCR. Measurement of Lipid profile was done using automated analyzer and serum endoglin and intracellular adhesion molecule (ICAM) levels were measured using ELISA technique. Relative expression of miR-34a and serum endoglin and ICAM levels were higher in patients than controls and in in patients with dyslipidemia (42 patients) compared to patients without dyslipidemia (78 patients) (p=0.001, 0.01 respectively). Linear regression analysis revealed strong an independent association between exosomal miR-34a expression with those of total cholesterol, LDL, serum endoglin and serum ICAM after adjustment of other cofactors. The utility of miR-34a as indicator for associated dyslipidemia was tested using ROC curve which revealed AUC: 0.73 with CI:0.63-0.83 and p=0.001. This is the first study that reported the altered expression of exosomal miR-34a among children and adolescents with T1DM. Moreover, association of miR-34a with markers of dyslipidemia and endothelial dysfunction was identified, suggesting that it could play a role in regulation of lipid metabolism and endothelial function in T1DM.
- 12 October 2020
- Published by Mathematical Modelling and Numerical Simulation with Applications in Journal of Pediatric Infectious Diseases
- Vol. 15  (06) , 299-306
Association between DNA Damage and Serum Levels of Copper, Zinc, and Selenium in Full-Term Neonates with Late-Onset Sepsis
Objective The alteration in certain trace elements is usually associated with impaired immune function and higher oxidative stress. Therefore, these elements are suggested to play an important role in the pathogenesis of neonatal sepsis. We aimed to evaluate copper (Cu), zinc (Zn), and selenium (Se) serum levels in full-term neonates with late-onset sepsis (LOS) and correlate these levels with DNA damage and other risk factors of sepsis. Methods The study included a group of 100 neonates diagnosed with sepsis serving as the case group and another one of 60 neonates serving as the control group. DNA damage was assessed using the comet assay method and trace elements were measured using inductively coupled plasma mass spectrometry. Results Compared with controls, the percentage of DNA damage was significantly elevated in patients with sepsis, while serum levels of Cu, Zn, and Se were markedly decreased (p = 0.001). A strong negative correlation was revealed between Se and DNA damage (r = −0.6, p = 0.001). However, no correlations were found between Cu or Zn and DNA damage. Univariate logistic regression analysis revealed that DNA damage as well as Cu, Zn, and Se serum levels can be considered as relevant risk factors for neonatal sepsis (p = 0.008, 0.004, 0.004, and 0.003, respectively). Receiver-operating characteristic curve analysis showed that the strongest indicator for neonatal sepsis was Se (area under the curve [AUC] = 0.94, confidence interval [CI] = 0.9–0.98, p = 0.001), followed by Cu (AUC = 0.9, CI = 0.85–0.96, p = 0.001), and then Zn (AUC = 0.87, CI = 0.8–0.93, p = 0.001). Conclusion The percentage of DNA damage may help in the assessment of neonatal sepsis severity. Altered levels of Cu, Zn, and Se may play significant role in the pathogenesis of neonatal sepsis. Se serum level is strongly correlated with percentage of DNA damage. Therefore, Se can predict the severity of LOS.
- 12 October 2020
- Published by Mathematical Modelling and Numerical Simulation with Applications in Journal of Pediatric Infectious Diseases
- Vol. 15  (06) , 299-306
Association between DNA Damage and Serum Levels of Copper, Zinc, and Selenium in Full-Term Neonates with Late-Onset Sepsis
Objective The alteration in certain trace elements is usually associated with impaired immune function and higher oxidative stress. Therefore, these elements are suggested to play an important role in the pathogenesis of neonatal sepsis. We aimed to evaluate copper (Cu), zinc (Zn), and selenium (Se) serum levels in full-term neonates with late-onset sepsis (LOS) and correlate these levels with DNA damage and other risk factors of sepsis. Methods The study included a group of 100 neonates diagnosed with sepsis serving as the case group and another one of 60 neonates serving as the control group. DNA damage was assessed using the comet assay method and trace elements were measured using inductively coupled plasma mass spectrometry. Results Compared with controls, the percentage of DNA damage was significantly elevated in patients with sepsis, while serum levels of Cu, Zn, and Se were markedly decreased (p = 0.001). A strong negative correlation was revealed between Se and DNA damage (r = −0.6, p = 0.001). However, no correlations were found between Cu or Zn and DNA damage. Univariate logistic regression analysis revealed that DNA damage as well as Cu, Zn, and Se serum levels can be considered as relevant risk factors for neonatal sepsis (p = 0.008, 0.004, 0.004, and 0.003, respectively). Receiver-operating characteristic curve analysis showed that the strongest indicator for neonatal sepsis was Se (area under the curve [AUC] = 0.94, confidence interval [CI] = 0.9–0.98, p = 0.001), followed by Cu (AUC = 0.9, CI = 0.85–0.96, p = 0.001), and then Zn (AUC = 0.87, CI = 0.8–0.93, p = 0.001). Conclusion The percentage of DNA damage may help in the assessment of neonatal sepsis severity. Altered levels of Cu, Zn, and Se may play significant role in the pathogenesis of neonatal sepsis. Se serum level is strongly correlated with percentage of DNA damage. Therefore, Se can predict the severity of LOS.
- 1 September 2020
- Published by Codon Publications in Allergologia et Immunopathologia
- Vol. 48  (5) , 458-464
Evaluation of miR-196a2 expression and Annexin A1 level in children with bronchial asthmaEvaluation of miR-196a2 expression and Annexin A1 level in children
Annexin A1 (ANXA1) is an important anti-inflammatory mediator that may play a significant role in bronchial asthma. MiR-196a2 can target ANXA1 and therefore may play a role in the pathogenesis of asthma. This is the first study which aimed to evaluate the expression of miR-196a2 in the serum of asthmatic children and correlate its expression with ANXA1 serum level and asthma severity. The study included 100 asthma patients who were subdivided into three groups (mild, moderate and severe) and 50 healthy control subjects. Assessment of miR-196a2 expression and ANXA1 serum level were done using quantitative reverse transcriptase PCR (RT qPCR) and Elisa techniques, respectively. Compared to the control group, asthmatic children showed an increased ANXA1 serum level and decreased expression of miR-196a2 (p=0.001). However, ANXA1 serum level was lower and miR-196a2 expression was higher in severe asthmatic patients compared to moderate asthmatic ones (p=0.01, 0.03). Pearson's correlation coefficient revealed no significant correlations between ANXA1 serum level and miR-196a2 expression in the patient group (p=0.9). Altered miR-196a2 expression and serum ANXA1 concentration may play a role in the pathogenesis of asthma. In addition, ANXA1 and miR-196a2 may represent potential diagnostic biomarkers for asthma and future targets for therapy.
- 1 September 2020
- Published by Codon Publications in Allergologia et Immunopathologia
- Vol. 48  (5) , 458-464
Evaluation of miR-196a2 expression and Annexin A1 level in children with bronchial asthmaEvaluation of miR-196a2 expression and Annexin A1 level in children
Annexin A1 (ANXA1) is an important anti-inflammatory mediator that may play a significant role in bronchial asthma. MiR-196a2 can target ANXA1 and therefore may play a role in the pathogenesis of asthma. This is the first study which aimed to evaluate the expression of miR-196a2 in the serum of asthmatic children and correlate its expression with ANXA1 serum level and asthma severity. The study included 100 asthma patients who were subdivided into three groups (mild, moderate and severe) and 50 healthy control subjects. Assessment of miR-196a2 expression and ANXA1 serum level were done using quantitative reverse transcriptase PCR (RT qPCR) and Elisa techniques, respectively. Compared to the control group, asthmatic children showed an increased ANXA1 serum level and decreased expression of miR-196a2 (p=0.001). However, ANXA1 serum level was lower and miR-196a2 expression was higher in severe asthmatic patients compared to moderate asthmatic ones (p=0.01, 0.03). Pearson's correlation coefficient revealed no significant correlations between ANXA1 serum level and miR-196a2 expression in the patient group (p=0.9). Altered miR-196a2 expression and serum ANXA1 concentration may play a role in the pathogenesis of asthma. In addition, ANXA1 and miR-196a2 may represent potential diagnostic biomarkers for asthma and future targets for therapy.
- 1 September 2019
- Published by Elsevier in Gene Reports
- Vol. 16
Expression of exosomal miR-21 and miR-29 in serum of children and adolescents with T1DM and persistent microalbuminuria
- 1 September 2019
- Published by Elsevier in Gene Reports
- Vol. 16
Expression of exosomal miR-21 and miR-29 in serum of children and adolescents with T1DM and persistent microalbuminuria
- 31 August 2019
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 32  (10) , 1171-1179
Micro-RNA 196a2 expression and miR-196a2 (rs11614913) polymorphism in T1DM: a pilot study
Background: Recent emerging evidence supports the role of miR-196a2 in various human diseases. However, its role in type 1 diabetes mellitus (T1DM) is still underestimated. We aimed, for the first time, to investigate the expression of miR-196a2 in T1DM and the association of miR-196a2 (rs11614913) polymorphism with susceptibility of T1DM in a sample of patients from Cairo, Egypt. Methods: The study included 150 patients and 150 healthy subjects. Evaluation of rs11614913 genotypes and miR-196a2 expression was done using the allelic discrimination and quantitative reverse transcriptase polymerase chain reaction (PCR) method, respectively. Results: The Hardy-Weinberg equilibrium of single nucleotide polymorphism(SNP) was detected among controls (p = 0.2). Our results revealed that the TT genotype was more frequent in patients (22.6%) than controls (10%) while the CC genotype was more frequent in controls (47.3%) than patients (39.3%) (p = 0.01). The frequency of the T allele was significantly higher in patients than in controls (41.7 vs. 31.3%), while the C allele was more frequent in controls (p = 0.008). After adjustment for traditional risk factors, the association of the TT genotype with T1DM remained significant (TT vs. CC, odds ration [OR] = 3.2, 95% confidence interval [CI]: 1.4–7.4, p = 0.005). Power analysis of the data yielded a statistical power of 80% for the miR-196a2 rs11614913 with T1DM. Relative expression of miR-196a2 showed significant decrease in patients compared to controls (median = 0.09, 0.5, interquartile range [IQR] = 0.03–1.6, 0.1–2.1). However, miR-196a2 expression showed no significant difference between different rs11614913 genotypes (p = 0.5). Conclusions: Our findings demonstrated that miR-196a rs11614913 is associated with T1DM and decreased expression of miR-196a2 may play a role in pathogenesis of T1DM.
- 31 August 2019
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 32  (10) , 1171-1179
Micro-RNA 196a2 expression and miR-196a2 (rs11614913) polymorphism in T1DM: a pilot study
Background: Recent emerging evidence supports the role of miR-196a2 in various human diseases. However, its role in type 1 diabetes mellitus (T1DM) is still underestimated. We aimed, for the first time, to investigate the expression of miR-196a2 in T1DM and the association of miR-196a2 (rs11614913) polymorphism with susceptibility of T1DM in a sample of patients from Cairo, Egypt. Methods: The study included 150 patients and 150 healthy subjects. Evaluation of rs11614913 genotypes and miR-196a2 expression was done using the allelic discrimination and quantitative reverse transcriptase polymerase chain reaction (PCR) method, respectively. Results: The Hardy-Weinberg equilibrium of single nucleotide polymorphism(SNP) was detected among controls (p = 0.2). Our results revealed that the TT genotype was more frequent in patients (22.6%) than controls (10%) while the CC genotype was more frequent in controls (47.3%) than patients (39.3%) (p = 0.01). The frequency of the T allele was significantly higher in patients than in controls (41.7 vs. 31.3%), while the C allele was more frequent in controls (p = 0.008). After adjustment for traditional risk factors, the association of the TT genotype with T1DM remained significant (TT vs. CC, odds ration [OR] = 3.2, 95% confidence interval [CI]: 1.4–7.4, p = 0.005). Power analysis of the data yielded a statistical power of 80% for the miR-196a2 rs11614913 with T1DM. Relative expression of miR-196a2 showed significant decrease in patients compared to controls (median = 0.09, 0.5, interquartile range [IQR] = 0.03–1.6, 0.1–2.1). However, miR-196a2 expression showed no significant difference between different rs11614913 genotypes (p = 0.5). Conclusions: Our findings demonstrated that miR-196a rs11614913 is associated with T1DM and decreased expression of miR-196a2 may play a role in pathogenesis of T1DM.
- Open Access
- 1 January 2019
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
- Vol. 15  (5) , 1247-1253
Expression of miRNAs-122, -192 and -499 in end stage renal disease associated with acute myocardial infarction
Introduction New diagnostic tools are needed to accurately detect acute myocardial infarction (AMI) in patients with end stage renal disease (ESRD) presenting with ischemic chest pain. We aimed in this study to investigate circulating miR-122, -192 and -499 expression levels in patients with...
- 1 January 2019
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
- Vol. 15  (5) , 1247-1253
Open AccessExpression of miRNAs-122, -192 and -499 in end stage renal disease associated with acute myocardial infarction
Introduction New diagnostic tools are needed to accurately detect acute myocardial infarction (AMI) in patients with end stage renal disease (ESRD) presenting with ischemic chest pain. We aimed in this study to investigate circulating miR-122, -192 and -499 expression levels in patients with...
- 1 September 2018
- Published by Elsevier in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 12  (5) , 643-648
Novel adipokines vaspin and irisin as risk biomarkers for cardiovascular diseases in type 2 diabetes mellitus
- 1 September 2018
- Published by Elsevier in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 12  (5) , 643-648
Novel adipokines vaspin and irisin as risk biomarkers for cardiovascular diseases in type 2 diabetes mellitus
- 1 June 2018
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 140, 304-313
Altered expression of WFS1 and NOTCH2 genes associated with diabetic nephropathy in T2DM patients
- 1 June 2018
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 140, 304-313
Altered expression of WFS1 and NOTCH2 genes associated with diabetic nephropathy in T2DM patients